View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Dashboards
  2. Jobs
January 24, 2022

ESG: North America sees hiring boom in clinical trial operations

The number of roles in North America made up 50.3% of total ESG jobs in the three months ending November.

By Data Journalism Team

North America extended its dominance for environmental, social, and governance (ESG) hiring among clinical trial operations industry companies in the three months ending November.

The number of roles in North America made up 50.3% of total ESG jobs – up from 44.6% in the same quarter last year.

That was followed by Asia-Pacific, which saw a two year-on-year percentage point change in ESG roles.

The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.

GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.

These key themes, which include environmental, social, and governance, are chosen to cover "any issue that keeps a CEO awake at night".

By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.

Countries seeing the most growth

The fastest growing country was the United States, which saw 42.2% of all ESG job adverts in the three months ending November last year, increasing to 46.8% in the three months ending November this year.

That was followed by India (up 1.2 percentage points), Canada (up 1.1), and Australia (up 0.5).

The top country for ESG roles in the clinical trial operations industry is the United States which saw 46.8% of all roles in the three months ending November.

Which cities are the biggest hubs?

Some 2.7% of all clinical trial operations industry ESG roles were advertised in Bridgewater (United States) in the three months ending November - more than any other city.

That was followed by Cambridge (United States) with 2.7%, Boston (United States) with 1.5%, and Shanghai (China) with 1.1%.

Related Companies

Free Whitepaper

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy